热疗癌症治疗市场－全球产业规模、份额、趋势、机会及预测（按设备类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球热疗癌症治疗市场预计将从 2025 年的 2.0125 亿美元成长到 2031 年的 2.8419 亿美元，复合年增长率为 5.92%。

热疗是治疗方法透过提高人体组织温度来破坏癌细胞并使其更容易接受同步放射线治疗和化疗的治疗方法。全球癌症负担日益加重，以及临床上对多模式治疗方法以提高难治性癌症患者存活率的需求，是推动这一市场成长的主要因素。近期疾病统计数据也印证了这个巨大需求。例如，美国癌症协会估计，到2025年，美国将新增2,041,910例癌症病例，凸显了有效辅助治疗性介入的迫切需求。

精准热疗系统高成本且技术复杂，是限制市场成长的主要障碍。部署能够确保均匀加热并保护健康组织的先进设备需要大量的资金投入和专业人员培训，这限制了许多医疗机构的普及。此外，不同地区的医保报销政策不尽相同，也阻碍了医疗机构采用这项技术，儘管其临床疗效已得到证实，但仍难以广泛应用并融入标准治疗方案。

市场驱动因素

全球肿瘤疾病发生率的不断上升是市场成长的主要驱动力。日益加重的疾病负担促使辅助性治疗广泛应用。不断攀升的癌症发生率迫使医疗系统采用诸如热疗等技术来增强标准治疗通讯协定的疗效。 2024年2月，世界卫生组织（世卫组织）在《全球癌症负担》报告中指出，2022年全球新增癌症病例约2,000万例。深部和难治性恶性肿瘤患者数量的增长尤为显着，这为专业热疗治疗创造了巨大的潜在市场。报告也指出，肺癌是全球新增病例最多的癌症，达250万例，也是深部局部热疗增强放射治疗效果的主要应用领域。

同时，公共和私人对癌症治疗基础设施投入的增加，以及对专业治疗中心的投资，正显着加速市场对热疗的接受度。医院和研究机构正积极升级其治疗设施，并引进先进的热疗系统，以改善患者获得多方面治疗的机会。专用设施的快速成长印证了这一趋势。根据中国领先的肿瘤专科医院派瑞克医疗发布的《2024年营运更新报告》显示，该院计划在年底前扩建，运作20台热疗设备。这种基础设施建设反映了医学界共识的转变，即把热疗融入主流肿瘤治疗流程，以最大限度地提高临床疗效。

市场挑战

精准热疗系统成本高且技术复杂，成为热疗癌症治疗市场扩张的主要障碍。实施这些先进的多效疗法需要医疗机构对精密设备进行大量投资，以确保均匀加热并保护正常组织。初始资本支出加上操作复杂系统所需的专业培训，造成了营运障碍，使得这些疗法主要局限于资金雄厚的研究中心，从而限制了其在临床环境中的广泛应用。

此外，报销范围的不稳定性严重削弱了将这项技术纳入标准治疗方案的财务可行性。当医疗机构无法为资本密集型治疗项目获得稳定的支付时，经济风险往往会超过临床效益。这种严峻的财务状况在近期的政策调整中显而易见：根据美国放射肿瘤学会2024年的公告，最终版的联邦医疗保险医师收费标准将把放射肿瘤服务的报销额降低约2%，延续了过去十年资本密集型疗法支付额持续下降的趋势。资金的减少直接阻碍了医疗机构购买和维护必要的热疗系统，从而抑制了市场成长。

市场趋势

磁共振引导即时温度监测系统的引入，满足了精确热剂量测定的关键需求，正在革新市场。这一趋势标誌着技术从静态加热向动态、影像引导介入技术的转变，使临床医生能够即时观察温度分布并即时调整能量输出。随着业界致力于检验这些精准平台，大量投资正在涌入。例如，Sensius在2025年6月的新闻稿中宣布，已获得1500万欧元的资金筹措，用于加速其精准热疗平台的国际临床部署，这表明市场对影像引导解决方案在头颈部恶性肿瘤治疗领域的商业性前景越来越有信心。

同时，市场正经历着向非侵入性深层组织微波和超音波疗法的重大转型，这种疗法消除了组织间导管置入的风险。随着高强度聚焦超音波（HIFU）技术的日趋成熟，这项转型正在加速。 HIFU提供了一种非切口治疗方案，无需住院，并能有效提高深部肿瘤的敏感性，以便于后续治疗。这些非侵入性设备在临床上的日益普及，体现在其全球使用量的激增。根据聚焦超音波基金会于2024年7月发布的《2024年产业现况报告》，全球病患治疗量较上年度成长了44%，凸显了非侵入性热疗技术的快速普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球热疗癌症治疗市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依设备类型（微波热疗设备、超音波热疗设备、红外线热疗设备、短波热疗设备）
  • 透过用途（前列腺癌、乳癌、子宫颈癌、皮肤癌、其他癌症）
  • 按最终使用者（医院/诊所、专科治疗中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美热疗癌症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲热疗癌症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区热疗癌症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲热疗癌症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲热疗癌症治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球热疗癌症治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Pyrexar Medical
• MagForce AG
• Hydrosun Medizintechnik GmbH
• Andromedic Srl
• YAMAMOTO VINITA CO., LTD
• OncoTherm Kft.
• Nanoprobes, Inc.
• Chongqing Haifu Medical Technology Co., Ltd.
• Novavida Integrative Medical Center
• InnoMedicus Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Hyperthermia Cancer Treatment Market is projected to expand from USD 201.25 Million in 2025 to USD 284.19 Million by 2031, registering a CAGR of 5.92%. Hyperthermia therapy involves raising the temperature of body tissues to destroy malignant cells and increase their sensitivity to accompanying radiation or chemotherapy protocols. The market is largely sustained by the growing global burden of cancer and the clinical necessity for multimodal treatments that enhance patient survival in refractory cases. This essential demand is underscored by recent disease statistics; for instance, the American Cancer Society estimates that 2,041,910 new cancer cases will be diagnosed in the United States in 2025, highlighting the critical need for effective adjunctive therapeutic interventions.

A significant barrier to market growth is the high cost and technical complexity inherent in precise thermal delivery systems. Implementing advanced equipment that guarantees uniform heating while protecting healthy tissue necessitates substantial capital investment and specialized personnel training, which limits accessibility in many healthcare institutions. Furthermore, inconsistent reimbursement policies across various regions frequently deter providers from adopting this technology, thereby restricting its reach and integration into standard care despite its demonstrated clinical efficacy.

Market Driver

The escalating global incidence of oncological disorders serves as the primary catalyst for market growth, as the rising disease burden mandates the widespread implementation of adjunctive therapies. As cancer rates increase, healthcare systems are driven to incorporate methods such as hyperthermia to boost the efficacy of standard treatment protocols. In February 2024, the World Health Organization reported in its 'Global Cancer Burden' release that approximately 20 million new cancer cases were documented globally in 2022. This growing patient volume is particularly significant for deep-seated and refractory malignancies, creating a large addressable market for specialized thermal treatments; notably, the same report identified lung cancer as the most common form worldwide with 2.5 million new cases, representing a key target for deep regional hyperthermia applications meant to potentiate radiation effects.

Simultaneously, the expansion of public and private funding for cancer care infrastructure is greatly accelerating market adoption, fueled by investments in specialized treatment centers. Hospitals and research institutes are actively upgrading their therapeutic facilities to include advanced thermal delivery systems, thereby improving patient access to multimodal care. This trend is demonstrated by the rapid growth of dedicated facilities; according to a 2024 operational update from Pyrexar Medical, a leading oncology hospital in China is expanding its capacity to operate 20 hyperthermia devices by the end of the year. Such infrastructural developments reflect a shifting medical consensus toward integrating thermal therapy into mainstream oncology workflows to maximize clinical success.

Market Challenge

The significant cost and technical intricacy associated with precise thermal delivery systems present a major obstacle to the expansion of the hyperthermia cancer treatment market. Adopting these advanced multimodal therapies requires healthcare facilities to invest heavily in sophisticated machinery capable of ensuring uniform heating while safeguarding healthy tissues. In addition to the initial capital expenditure, the necessity for specialized training to operate these complex systems creates an operational barrier, effectively limiting adoption to well-funded research centers and restricting widespread clinical accessibility.

Moreover, variability in reimbursement coverage severely compromises the financial feasibility of integrating this technology into standard practice. When providers are unable to secure consistent payment for capital-intensive procedures, the economic risks often outweigh the clinical benefits. This difficult fiscal landscape is evidenced by recent policy adjustments; according to the American Society for Radiation Oncology in 2024, the finalized Medicare Physician Fee Schedule imposed a reimbursement reduction of approximately 2% for radiation oncology services, continuing a decade-long trend of declining payments for equipment-heavy treatments. Such diminishing financial support directly hampers the ability of medical providers to acquire and maintain necessary hyperthermia systems, thereby stalling market growth.

Market Trends

The adoption of MRI-Guided Real-Time Temperature Monitoring Systems is revolutionizing the market by fulfilling the critical requirement for precise thermal dosimetry. This trend marks a technological advancement from static heating to dynamic, image-guided interventions that enable clinicians to visualize temperature distribution in real-time and adjust energy delivery instantly. The industry's focus on validating these precision platforms is attracting significant investment; for example, Sensius B.V. announced in a June 2025 press release that it secured €15 million in funding to accelerate the international clinical deployment of its precision thermotherapy platform, signaling growing commercial confidence in image-guided solutions for head and neck malignancies.

At the same time, the market is undergoing a decisive shift toward Non-Invasive Deep Tissue Microwave and Ultrasound Modalities, which remove the risks associated with interstitial catheter placement. This transition is gaining momentum as high-intensity focused ultrasound (HIFU) technologies mature, providing non-incisional options that effectively sensitize deep-seated tumors to concurrent therapies without requiring hospitalization. The expanding clinical presence of these non-invasive devices is reflected in a surge in global utilization; according to the Focused Ultrasound Foundation's '2024 State of the Field Report' released in July 2024, the sector saw a 44% increase in the number of patient treatments worldwide compared to the prior year, highlighting the rapid mainstream acceptance of non-invasive thermal techniques.

Key Market Players

• Pyrexar Medical
• MagForce AG
• Hydrosun Medizintechnik GmbH
• Andromedic Srl
• YAMAMOTO VINITA CO., LTD
• OncoTherm Kft.
• Nanoprobes, Inc.
• Chongqing Haifu Medical Technology Co., Ltd.
• Novavida Integrative Medical Center
• InnoMedicus Ltd.

Report Scope

In this report, the Global Hyperthermia Cancer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hyperthermia Cancer Treatment Market, By Device Type

• Microwave Hyperthermia Device
• Ultrasound Hyperthermia Device
• Infrared Hyperthermia Device
• Short-wave Hyperthermia Device

Hyperthermia Cancer Treatment Market, By Application

• Prostate Cancer
• Breast Cancer
• Cervical Cancer
• Skin Cancer
• Other Cancers

Hyperthermia Cancer Treatment Market, By End User

• Hospitals & Clinics
• Specialty Centers
• Others

Hyperthermia Cancer Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hyperthermia Cancer Treatment Market.

Available Customizations:

Global Hyperthermia Cancer Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hyperthermia Cancer Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, Short-wave Hyperthermia Device)
  • 5.2.2. By Application (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, Other Cancers)
  • 5.2.3. By End User (Hospitals & Clinics, Specialty Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hyperthermia Cancer Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hyperthermia Cancer Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Hyperthermia Cancer Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Hyperthermia Cancer Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Hyperthermia Cancer Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hyperthermia Cancer Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Hyperthermia Cancer Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Hyperthermia Cancer Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Hyperthermia Cancer Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Hyperthermia Cancer Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Hyperthermia Cancer Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hyperthermia Cancer Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Hyperthermia Cancer Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Hyperthermia Cancer Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Hyperthermia Cancer Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Hyperthermia Cancer Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Hyperthermia Cancer Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hyperthermia Cancer Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Hyperthermia Cancer Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Hyperthermia Cancer Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Hyperthermia Cancer Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hyperthermia Cancer Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Hyperthermia Cancer Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Hyperthermia Cancer Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hyperthermia Cancer Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Pyrexar Medical
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. MagForce AG
• 15.3. Hydrosun Medizintechnik GmbH
• 15.4. Andromedic Srl
• 15.5. YAMAMOTO VINITA CO., LTD
• 15.6. OncoTherm Kft.
• 15.7. Nanoprobes, Inc.
• 15.8. Chongqing Haifu Medical Technology Co., Ltd.
• 15.9. Novavida Integrative Medical Center
• 15.10. InnoMedicus Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer